Zobrazeno 1 - 10
of 465
pro vyhledávání: '"Dan H Moore"'
Autor:
Aejaz Sayeed, Gloria Luciani-Torres, Zhenhang Meng, James L Bennington, Dan H Moore, Shanaz H Dairkee
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e67191 (2013)
Normal cellular phenotypes that serve an oncogenic function during tumorigenesis are potential candidates for cancer targeting drugs. Within a subset of invasive primary breast carcinoma, we observed relatively abundant expression of Tetherin, a cell
Externí odkaz:
https://doaj.org/article/c623549b905945aa9ec9204a7842ebc2
Autor:
Rosemary J. Akhurst, Boris C. Bastian, Ervin H. Epstein, Dan H. Moore, Jesus Perez-Losada, Frederic F. Clermont, Elise F. Saunier, Katie Ridd, Kelly A. Harradine
Supplementary Data from Elevated Cutaneous Smad Activation Associates with Enhanced Skin Tumor Susceptibility in Organ Transplant Recipients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d77ef7646c59fbdb3f2b821057c43efd
https://doi.org/10.1158/1078-0432.22440289
https://doi.org/10.1158/1078-0432.22440289
Autor:
Sean D. McAllister, Pierre-Yves Desprez, Garret L. Yount, Dan H. Moore, Chandani Limbad, Juanita Allison, Arash Pakdel, Jasmine Lee, Maxx P. Horowitz, Anne J. Zielinski, Darryl Lau, Rigel T. Christian, Jahan P. Marcu
Supplementary Figure 1 from Cannabidiol Enhances the Inhibitory Effects of Δ9-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6d2feabcdd57f1d4d0af302f3782c7a
https://doi.org/10.1158/1535-7163.22484864
https://doi.org/10.1158/1535-7163.22484864
Autor:
Sean D. McAllister, Pierre-Yves Desprez, Garret L. Yount, Dan H. Moore, Chandani Limbad, Juanita Allison, Arash Pakdel, Jasmine Lee, Maxx P. Horowitz, Anne J. Zielinski, Darryl Lau, Rigel T. Christian, Jahan P. Marcu
Supplementary Figure 2 from Cannabidiol Enhances the Inhibitory Effects of Δ9-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84a1fbeab08858f1c7542720339d909d
https://doi.org/10.1158/1535-7163.22484861
https://doi.org/10.1158/1535-7163.22484861
Autor:
Rosemary J. Akhurst, Boris C. Bastian, Ervin H. Epstein, Dan H. Moore, Jesus Perez-Losada, Frederic F. Clermont, Elise F. Saunier, Katie Ridd, Kelly A. Harradine
Purpose: Nonmelanoma skin cancer incidence is enhanced >50-fold in patients taking antirejection drugs (ARD) following organ transplantation. Preclinical studies suggest that ARD treatment increases transforming growth factor-β1 (TGF-β1) levels, wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23d1305de02cb2d765327d16e3d66c22
https://doi.org/10.1158/1078-0432.c.6517639.v1
https://doi.org/10.1158/1078-0432.c.6517639.v1
Autor:
Sean D. McAllister, Pierre-Yves Desprez, Garret L. Yount, Dan H. Moore, Chandani Limbad, Juanita Allison, Arash Pakdel, Jasmine Lee, Maxx P. Horowitz, Anne J. Zielinski, Darryl Lau, Rigel T. Christian, Jahan P. Marcu
The cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptor agonist Δ9-tetrahydrocannabinol (THC) has been shown to be a broad-range inhibitor of cancer in culture and in vivo, and is currently being used in a clinical trial for the treatment of gliobl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14a3a80d918daf9144f0d27da2167a95
https://doi.org/10.1158/1535-7163.c.6531623
https://doi.org/10.1158/1535-7163.c.6531623
Autor:
Sean D. McAllister, Pierre-Yves Desprez, Garret L. Yount, Dan H. Moore, Chandani Limbad, Juanita Allison, Arash Pakdel, Jasmine Lee, Maxx P. Horowitz, Anne J. Zielinski, Darryl Lau, Rigel T. Christian, Jahan P. Marcu
Supplementary Table 1, Figure Legends 1-2 from Cannabidiol Enhances the Inhibitory Effects of Δ9-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d6cbd697f599c63050635d0a7f61133
https://doi.org/10.1158/1535-7163.22484858
https://doi.org/10.1158/1535-7163.22484858
Autor:
Dan H. Moore, Joe W. Gray, Heidi S. Feiler, Lakshmi R. Jakkula, Zhenhang Meng, Stacey Champion, Gloria Luciani, Aejaz Sayeed, Shanaz H. Dairkee
Inherent cancer phenotypes that are independent of fluctuating cross-talk with the surrounding tissue matrix are highly desirable candidates for targeting tumor cells. Our novel study design uses epithelial cell lines derived from low versus high his
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::418728df3c8436ec43b886e1162a3e48
https://doi.org/10.1158/0008-5472.c.6500349
https://doi.org/10.1158/0008-5472.c.6500349
Autor:
Dan H. Moore, Joe W. Gray, Heidi S. Feiler, Lakshmi R. Jakkula, Zhenhang Meng, Stacey Champion, Gloria Luciani, Aejaz Sayeed, Shanaz H. Dairkee
Supplementary Table 3 from Immutable Functional Attributes of Histologic Grade Revealed by Context-Independent Gene Expression in Primary Breast Cancer Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20d4ece5819058067bd353b12dd0b3f7
https://doi.org/10.1158/0008-5472.22382871.v1
https://doi.org/10.1158/0008-5472.22382871.v1
Autor:
Sean D. McAllister, Pierre-Yves Desprez, Dan H. Moore, Garret L. Yount, Robert Arauz, Sabeena Khan, Daniel Nguyen, Yayoi Fukuyo, Arash Pakdel, Rumi Kawamura, Isabel Adrados, Juanita Allison, Eric Singer, Chandani Limbad, Ryuichi Murase, Liliana Soroceanu
PDF file - 2804K, Supplementary Figure 1. Id-1 levels are increased in the CD133+ GBM cells. Supplementary Figure 2. Id-1 knockdown inhibits U251 cell neurosphere formation. Supplementary Figure 3. Id-1 knockdown in GBM cells increases survival in an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c44da5eca0559c37be305a692ca8bd41
https://doi.org/10.1158/0008-5472.22399802.v1
https://doi.org/10.1158/0008-5472.22399802.v1